HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of Euro-Global Conference on Biotechnology and Bioengineering

June 14-15 | Hybrid Event

June 14-15, 2023 | Rome, Italy
ECBB 2023

Mbawala Augustin

Mbawala Augustin, Speaker at Speaker 2023
University of Ngaoundere, Cameroon
Title: Bio-Valorization of Bioemulsifiers/Biosurfactants Produced by Lactobacilli Isolated From an Indigenous Fermented Milk (Pendidam) Of the Adamaoua Region of Cameroon : A Bio-Therapeutic Perspective to Fight Against Aids, COVID-19, Influenza, Hepatitis B and C, Myocardial Infarction and Cerebro-Vascular AccidentNowadays, the number of outbreaks of epi

Abstract:

Nowadays, the number of outbreaks of epidemics associated with viral infection and mortality due to myocardial infarction (MI) and cerebrovascular accident (CVA) has increased significantly. The recent emergence of several strains of Influenza viruses with pandemic potentials as well as the COVID-19 and AIDS pandemics has led to a growing interest in the control of these infections to preserve human health. Firstly, Influenza viruses, Coronaviruses, HIV, Hepatitis B and C viruses, etc. belong to the group of enveloped viruses with a lipid membrane. Secondly, MI and CVA are usually caused by an obstruction of the blood vessels by a blood clot leading to the stop of blood circulation. Bioemulsifiers/Biosurfactants (BE/BS) are surface-active amphiphilic bio-molecules with less toxicity produced by lactobacilli “GRAS (Generally Recognized As Safe) status” isolated from traditional fermented milk (Pendidam) of the Adamaoua Region (Cameroon) that possess multiple functional properties. Their emulsifying properties for example could be used to disintegrate effectively the viral envelope leading to the death of the virus and to solubilize the blood clot leading to the recovery of the blood circulation in the affected vessel. The aim of the present report is to exploit the potential properties of BE/BS produced by lactobacilli isolated from Pendidam and to value them as bio-therapeutic alternatives in the fight against AIDS, COVID-19, Influenza, Hepatitis B and C, MI and CVA.

Audience take away notes:

  • New approaches of therapeutic understanding
  • Concretization of public expectations
  • Application of novel therapeutic technique
  • Patient recovering while minimizing unwanted side effects due to current treatments

Biography:

Mbawala Augustin studied and obtained his Bachelor's degree in 1981 at the University of Yaounde and received his Ph.D. degree in 1990 at the University of Nancy 1. Now, he is the Head of the Laboratory of Food Microbiology and Biotechnology of ENSAI at the University of Ngaoundere. He has published at least 33 papers in Journals with DOI and high impact factor and a book on the Challenges of Indigenous Fermented Milks from Cameroon and Chad. His research team is working actually on a project concerning the potential utilizations of Bioemulsifiers/Biosurfactants in health care.

Watsapp